RE: RE: RE: 17 Nov 2009 Washington D.C., USA
I googel all names of Pharma companies that will present to this Congress. Except GENZ, SSS, Sanofi-Aventis, Roche and Pfizer, all others are private.
Of course, as we know, SSS is the only one on market which trangige far far away from $ 1.
How can it be possible to be invited to share their knowledge into such of giants table without attract more big investors for built a respectable PS?
I can't believe that the organizers have invited SSS just to fill a hole in their program or to demonstrate that their cellullar therapy will never meet a successful achievement!!!
Did you see the name of this event?
Commercial and development opportunities for big pharma, biotech, investors and research organizations
Well, if we see SSS meet a other draff under 0,13 after that ... we all will have to wait after some more trials results or wait after SSS move in Miami this coming spring.